Turning Point and LaNova enter license agreement for LM-302 and collaboration on ADC programs May 6, 2022
NexImmune's AIM ACT to be studied in Columbia University's PDO models of HPV-associated cancers April 27, 2022
ViGeneron and Daiichi Sankyo enter follow-on collaboration for gene therapy for eye diseases April 26, 2022
Turnstone Biologics collaborates with University of Montreal for development of TIL therapy April 26, 2022
n-Lorem receives funding to support ASO discovery for nano-rare neurodevelopmental diseases April 22, 2022
Codexis and seqWell partner to accelerate commercialization of genomics workflow solutions April 22, 2022
RSS